サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386203

A型肝炎ワクチン市場レポート：2030年までの動向、予測、競合分析

Hepatitis A Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

A型肝炎ワクチン市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

A型肝炎ワクチンの動向と予測

世界のA型肝炎ワクチン市場は、2024年から2030年までのCAGRが3.6%で、2030年までに推定10億米ドルに達すると予想されます。この市場の主な促進要因は、予防接種の重要性に対する意識の高まり、A型肝炎の蔓延を抑制するための政府の支援策、新興国での医療インフラの整備が進んでいることです。世界のA型肝炎ワクチン市場の将来は、政府機関や民間の市場にビジネスチャンスがあり、有望視されています。

A型肝炎ワクチン市場洞察

Lucintelの予測では、弱毒生ワクチンは自然感染を予防し、強力かつ長期的な免疫反応を構築するために広く使用されているため、予測期間中に高い成長が見込まれます。

この市場の中では、政府機関が予測期間中に高い成長を示すことが期待されています。

アジア太平洋は、継続的な人口増加とA型肝炎感染者数の増加により、予測期間中に最も高い成長が見込まれます。

市場規模・推定：A型肝炎ワクチンの市場規模を金額（10億米ドル）で推定。

動向と予測分析：各種セグメント別、地域別の市場動向（2018年～2023年）と予測（2024年～2030年）。

市場セグメンテーション分析：a型肝炎ワクチン市場規模をタイプ別、用途別、地域別に金額（10億米ドル）で推定

地域分析：a型肝炎ワクチン市場の北米、欧州、アジア太平洋、その他世界の地域内訳。

成長機会：A型肝炎ワクチン市場のタイプ別、用途別、地域別の成長機会分析。

戦略分析：A型肝炎ワクチン市場のM&A、新製品開発、競合情勢など。

ポーターのファイブフォースモデルに基づく業界の競合強度分析。

本レポートは以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のA型肝炎ワクチン市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018～2030年の市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のA型肝炎ワクチン市場動向（2018～2023年）と予測（2024～2030年）
  • 種類別の世界のA型肝炎ワクチン市場
    • 不活化ワクチン
    • 弱毒生ワクチン
  • 用途別の世界のA型肝炎ワクチン市場
    • 政府機関
    • 民間
    • その他

第4章 2018～2030年の地域別の市場動向と予測分析

  • 地域別の世界のA型肝炎ワクチン市場
  • 北米のA型肝炎ワクチン市場
  • 欧州のA型肝炎ワクチン市場
  • アジア太平洋のA型肝炎ワクチン市場
  • その他地域のA型肝炎ワクチン市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界のA型肝炎ワクチン市場の成長機会
    • 用途別の世界のA型肝炎ワクチン市場の成長機会
    • 地域別の世界のA型肝炎ワクチン市場の成長機会
  • 世界のA型肝炎ワクチン市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のA型肝炎ワクチン市場の生産能力拡大
    • 世界のA型肝炎ワクチン市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • GlaxoSmithKline
  • Merck & Co
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute of Biological
  • KM Biologics
  • IMBCA
  • ChangSheng
  • Convac
目次

Hepatitis A Vaccine Trends and Forecast

The future of the global hepatitis A vaccine market looks promising with opportunities in the government institution and private sector markets. The global hepatitis A vaccine market is expected to reach an estimated $1.0 billion by 2030 with a CAGR of 3.6% from 2024 to 2030. The major drivers for this market are rising awareness about the importance of immunization, supportive government initiatives to control the spread of hepatitis A, and growing healthcare infrastructure in developing countries.

A more than 150-page report is developed to help in your business decisions.

Hepatitis A Vaccine by Segment

The study includes a forecast for the global hepatitis A vaccine by type, application, and region.

Hepatitis A Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Inactivated Vaccine
  • Live Attenuated Vaccine

Hepatitis A Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Government Institution
  • Private Sector
  • Others

Hepatitis A Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Hepatitis A Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hepatitis A vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hepatitis A vaccine companies profiled in this report include-

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute Of Biological
  • KM Biologics
  • IMBCA
  • Changsheng
  • Convac

Hepatitis A Vaccine Market Insights

Lucintel forecasts that live attenuated vaccine is expected to witness higher growth over the forecast period due to its widespread usage to prevent natural infection and build a strong and long-lasting immune response.

Within this market, government institution is expected to witness higher growth over the forecast period.

APAC is expected to witness highest growth over the forecast period due to continous growth of population base and rising number of hepatitis A infection affected population in the region.

Features of the Global Hepatitis A Vaccine Market

Market Size Estimates: Hepatitis a vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hepatitis a vaccine market size by type, application, and region in terms of value ($B).

Regional Analysis: Hepatitis a vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hepatitis A vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hepatitis A vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the hepatitis A vaccine market size?

Answer: The global hepatitis A vaccine market is expected to reach an estimated $1.0 billion by 2030.

Q.2 What is the growth forecast for hepatitis A vaccine market?

Answer: The global hepatitis A vaccine market is expected to grow with a CAGR of 3.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the hepatitis A vaccine market?

Answer: The major drivers for this market are rising awareness about the importance of immunization, supportive government initiatives to control the spread of hepatitis A, and growing healthcare infrastructure in developing countries.

Q4. What are the major segments for hepatitis A vaccine market?

Answer: The future of the hepatitis A vaccine market looks promising with opportunities in the government institution and private sector markets.

Q5. Who are the key hepatitis A vaccine market companies?

Answer: Some of the key hepatitis A vaccine companies are as follows:

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute Of Biological
  • KM Biologics
  • IMBCA
  • Changsheng
  • Convac

Q6. Which hepatitis A vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that live attenuated vaccine is expected to witness higher growth over the forecast period due to its widespread usage to prevent natural infection and build a strong and long-lasting immune response.

Q7. In hepatitis A vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to continous growth of population base and rising number of hepatitis A infection affected population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the hepatitis A vaccine market by type (inactivated vaccine and live attenuated vaccine), application (government institution, private sector, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Hepatitis A Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Hepatitis A Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Hepatitis A Vaccine Market by Type
    • 3.3.1: Inactivated vaccine
    • 3.3.2: Live Attenuated Vaccine
  • 3.4: Global Hepatitis A Vaccine Market by Application
    • 3.4.1: Government Institution
    • 3.4.2: Private Sector
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Hepatitis A Vaccine Market by Region
  • 4.2: North American Hepatitis A Vaccine Market
    • 4.2.2: North American Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others
  • 4.3: European Hepatitis A Vaccine Market
    • 4.3.1: European Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
    • 4.3.2: European Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others
  • 4.4: APAC Hepatitis A Vaccine Market
    • 4.4.1: APAC Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
    • 4.4.2: APAC Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others
  • 4.5: ROW Hepatitis A Vaccine Market
    • 4.5.1: ROW Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
    • 4.5.2: ROW Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Hepatitis A Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Hepatitis A Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global Hepatitis A Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Hepatitis A Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Hepatitis A Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hepatitis A Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: Merck & Co
  • 7.3: Sanofi
  • 7.4: Sinovac
  • 7.5: Zhejiang Pukang
  • 7.6: Changchun Institute of Biological
  • 7.7: KM Biologics
  • 7.8: IMBCA
  • 7.9: ChangSheng
  • 7.10: Convac